Predicting the Long-term Outcomes of Biologics in Psoriasis Patients using Machine Learning.

Predicting the Long-term Outcomes of Biologics in Psoriasis Patients using Machine Learning. Br J Dermatol. 2019 Nov 28;: Authors: Emam S, Du AX, Surmanowicz P, Thomsen SF, Greiner R, Gniadecki R Abstract Despite the vast amount of data on the efficacy of biologics in psoriasis treatment, therapeutic decision-making is still based on a trial-and-error approach. In a real world setting over 50% of patients needing dose adjustment during therapy and 20-50% of patients experiencing a relapse of the disease requiring a switch to another medication. PMID: 31778205 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31778205?dopt=Abstract

Source: The British Journal of Dermatology - November 27, 2019 Category: Dermatology Authors: Emam S, Du AX, Surmanowicz P, Thomsen SF, Greiner R, Gniadecki R Tags: Br J Dermatol Source Type: research